In the IL-4-rich environment of acute AD, stimulation of TLR2, with SA-derived lipoteichoic acid results in upregulation of IL-12/IL-10 ratio and IFN-γ that provoke chronic inflammation [105,106]. Here, TLR2 is linked to Alzheimer disease.